Join us for our upcoming collaborative webinar with 

 

Interest in nanotechnology, including both polymeric and lipidic nanoparticles, has grown significantly in the last decade. The tremendous success of mRNA-lipid nanoparticle (LNP)-based vaccines during the COVID-19 pandemic has led to further explosive growth in development and created new opportunities in this area. The unprecedented speed of development of the COVID-19 LNP-based vaccines was, to a large extent, built upon foundational work performed over the last 10–15 years in LNP platform development.

 

This is why Dolomite and Phosphorex partnered to bridge their complementary areas of expertise:

Dolomite Microfluidics leverages 20 years of industry-leading Microfluidics technology, product engineering and applications knowledge to design and manufacture cutting-edge particle generation platforms, such as the Automated Nanoparticle (ANP) System enabling customers to fast-track their own product development processes.

 

Phosphorex brings extensive expertise and capabilities in nanoparticle-based formulations, analytical characterization, process development, scale-up, and manufacturing. Phosphorex has developed a comprehensive approach to optimize the LNP development process and streamline transition into clinical manufacturing.

 

Join this collaborative webinar hosted by Dolomite & Phosphorex experts Dr Julia Rashba-Step, Dr Cate O’Brien, Dr Nicholas Boylan and Dr Nicholas Karabin, as they share their insights about the most important considerations when making liposomes and lipid nanoparticles (LNPs) with microfluidics.

 

 

Sign me up!

 

 

Webinar details:

 

 

Date: Tuesday, 8th March 2022

Time: 09:00 PST | 12:00 EST | 17:00 GMT

Event type: Webinar – Live

 

We will discuss:

  • Current state of LNP fabrication with the emphasis on formulation, process and analytical characterization
  • Microfluidic approaches for control of LNP self-assembly
  • Framework for planning and execution of LNP based products
  • Challenges and opportunities in LNP fabrication and downstream process using clinically relevant unit operations
  • Case studies of successful LNP based projects to illustrate potential challenges and solutions

 

Register me now!

 

Interested to learn more about liposomes?

Read our new Application Note on the controlled synthesis of lipid nanoparticles using the ANP System and learn about the research done by our Experts on the key parameters involved in tuning LNPs’ size, and a comparison between the protocol and continuous mode to demonstrate the transferability of the process parameters for bulk production of LNPs.

Download App Note

Have any questions for us before the webinar?